本刊讯2014年1月26日,国家食品药品监督管理总局发布第59期《药品不良反应信息通报》,提醒关注头孢唑林注射剂严重不良反应。头孢唑林为β-内酰胺类广谱抗生素,为第1代注射用头孢菌素。该药对大多数敏感的革兰阳性球菌与常见的革兰阴性杆菌均有较强的抗菌作用。目前,我国批准的头孢唑林注射剂有注射用头孢唑林钠和注射用五水头孢唑林钠两种。 Xinhua News January 26, 2014, the State Food and Drug Administration released the first 59 “Adverse Drug Reaction Information”, reminding the attention of cefazolin injection serious adverse reactions. Cefazolin is β-lactam broad-spectrum antibiotics, for the first generation of cephalosporins for injection. The drug has strong antibacterial effect on most sensitive gram-positive cocci and common gram-negative bacilli. At present, China has approved cefazolin injection with cefazolin sodium for injection and cefazolin sodium pentaspirone for injection.